Display Settings:

Format
Sort by

Send to:

Choose Destination

    Results: 4

    1.

    Structural basis for ubiquitin-mediated dimerization and activation of the ubiquitin protein ligase Cbl-b.

    Peschard P, Kozlov G, Lin T, Mirza IA, Berghuis AM, Lipkowitz S, Park M, Gehring K.

    Mol Cell. 2007 Aug 3;27(3):474-85.

    PMID:
    17679095
    [PubMed - indexed for MEDLINE]
    2.

    Specific Grb2-mediated interactions regulate clathrin-dependent endocytosis of the cMet-tyrosine kinase.

    Li N, Lorinczi M, Ireton K, Elferink LA.

    J Biol Chem. 2007 Jun 8;282(23):16764-75. Epub 2007 Apr 20.

    PMID:
    17449471
    [PubMed - indexed for MEDLINE]
    Free Article
    3.

    Somatic mutations lead to an oncogenic deletion of met in lung cancer.

    Kong-Beltran M, Seshagiri S, Zha J, Zhu W, Bhawe K, Mendoza N, Holcomb T, Pujara K, Stinson J, Fu L, Severin C, Rangell L, Schwall R, Amler L, Wickramasinghe D, Yauch R.

    Cancer Res. 2006 Jan 1;66(1):283-9.

    PMID:
    16397241
    [PubMed - indexed for MEDLINE]
    Free Article
    4.

    A conserved DpYR motif in the juxtamembrane domain of the Met receptor family forms an atypical c-Cbl/Cbl-b tyrosine kinase binding domain binding site required for suppression of oncogenic activation.

    Peschard P, Ishiyama N, Lin T, Lipkowitz S, Park M.

    J Biol Chem. 2004 Jul 9;279(28):29565-71. Epub 2004 Apr 29.

    PMID:
    15123609
    [PubMed - indexed for MEDLINE]
    Free Article

      Display Settings:

      Format
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk